Australia's most trusted
source of pharma news
Thursday, 10 July 2025
">
Posted 10 July 2025 AM
One of the best known communications executives in corporate America, Pfizer's Sally Susman, is leaving after close to 20 years following a decision by the company to integrate its Corporate Affairs function elsewhere.
CEO Albert Bourla wrote to staff yesterday to announce Susman's departure, which he described as another important step to "prioritise focus, speed and simplify our work processes".
Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.
Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.